Recent Insider Transactions - Contineum Therapeutics (NASDAQ: CTNM)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ CTNM Contineum Therapeutics

Healy John Stephen / officer: General Counsel and Corp Sec

01/31/2025

Buy

$9.79

63,589

$623K

63,589

NASDAQ CTNM Contineum Therapeutics

Slover Peter T / officer: Chief Financial Officer

01/31/2025

Buy

$9.79

110,000

$1.077M

110,000

NASDAQ CTNM Contineum Therapeutics

Lorrain Daniel S. / officer: Chief Scientific Officer

01/31/2025

Buy

$9.79

110,000

$1.077M

110,000

NASDAQ CTNM Contineum Therapeutics

Lorrain Daniel S. / officer: Chief Scientific Officer

01/31/2025

Buy

$9.79

3,700

$36K

3,700

NASDAQ CTNM Contineum Therapeutics

Huhn Stephen L. / officer: CMO & Sr VP, Clinical Dev.

01/31/2025

Buy

$9.79

110,000

$1.077M

110,000

NASDAQ CTNM Contineum Therapeutics

Stengone Carmine N. / director, officer: CEO and President

01/31/2025

Buy

$9.79

300,000

$2.937M

300,000